Status:
UNKNOWN
Juvenile Systemic Sclerosis, a Retrospective Epidemiological Study on a French Cohort
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Juvenile Systemic Sclerosis
Eligibility:
All Genders
1-17 years
Brief Summary
Scleroderma is an inflammatory attack of the vessels leading to localized or multisystemic sclerosis. It is a rare autoimmune pathology in pediatrics. The incidence in pediatrics is very low (about 4...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Minor subject (\<18 years old)
- Diagnosis of systemic sclerosis between 01/01/2012 and 30/06/2022.
- Subject (and/or his parental authority) who has not expressed, after being informed, his opposition to the reuse of his data for the purposes of this research.
- Exclusion criteria:
- \- Subject (or his parents) having expressed his (their) opposition to participating in the study
Exclusion
Key Trial Info
Start Date :
March 3 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 3 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06019234
Start Date
March 3 2023
End Date
October 3 2024
Last Update
November 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Pédiatrie 1 - CHU de Strasbourg - France
Strasbourg, France, 67091